Understanding how sleep and circadian rhythms affect obesity risk in infants
Identifying mechanisms of maternal-infant obesity risk transmission: The role of appetite, sleep, and circadian rhythms
['FUNDING_R01'] · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · NIH-10895523
This study is looking at how babies' sleep habits and body clocks can affect their hunger and risk of becoming overweight, and it’s for pregnant women in their third trimester who want to help their little ones develop healthy eating patterns right from the start.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PITTSBURGH AT PITTSBURGH (nih funded) |
| Locations | 1 site (PITTSBURGH, UNITED STATES) |
| Trial ID | NIH-10895523 on ClinicalTrials.gov |
What this research studies
This research investigates how sleep patterns and circadian rhythms in infants influence their appetite and obesity risk. By studying pregnant individuals in their third trimester, the project aims to understand the relationship between maternal and infant sleep cycles and their effects on infant appetite development. The study will involve monitoring sleep and appetite traits in infants to identify potential behavioral interventions that could reduce obesity risk. The findings could lead to new strategies for promoting healthier weight gain patterns from infancy.
Who could benefit from this research
Good fit: Ideal candidates for participation include pregnant individuals in their third trimester with a body mass index of 18.5 kg/m2 or higher.
Not a fit: Patients who are not pregnant or who have a body mass index below 18.5 kg/m2 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective interventions that help prevent obesity in infants and improve long-term health outcomes.
How similar studies have performed: While there is emerging data on the relationship between sleep, circadian rhythms, and appetite, this specific approach is novel and has not been extensively tested.
Where this research is happening
PITTSBURGH, UNITED STATES
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH — PITTSBURGH, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CONLON, RACHEL P. KOLKO — UNIVERSITY OF PITTSBURGH AT PITTSBURGH
- Study coordinator: CONLON, RACHEL P. KOLKO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.